Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart

Neuropeptides

Volumn 38, Issue 5, 2004, Pages 289-297

  Sawmiller, Darrell R ^a   Henning, Robert J ^a   Cuevas, Javier ^a   Dehaven, Wayne I ^a   Vesely, David L ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Adenosine; Cyclic AMP; Cyclic GMP; Immunohistochemistry; Receptors; RT PCR; Sodium nitroprusside; Vasodilation

Indexed keywords

ADENOSINE; POTASSIUM; SODIUM; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY VASCULAR RESISTANCE; HEART MUSCLE CONTRACTILITY; HEART PERFUSION; ISOLATED HEART; MALE; NONHUMAN; OXYGEN CONSUMPTION; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; REDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SODIUM BLOOD LEVEL;

ADENOSINE; ANIMALS; CALCIUM; CORONARY CIRCULATION; CORONARY VESSELS; CYCLIC AMP; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART; MALE; MYOCARDIUM; NITROPRUSSIDE; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE, TYPE II; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; VASOACTIVE INTESTINAL PEPTIDE; VASODILATOR AGENTS;

EID: 4644292147     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2004.05.008     Document Type: Article

References (34)

1. Accili E.A., Buchan A.M.J., Kwok Y.N., Ledsome J.R., Brown J.C. Presence and actions of vasoactive intestinal peptide in the isolated rabbit heart. Can. J. Physiol. Pharmacol. 73:1995;134-139
2. Anderson F.L., Kralios A.C., Hershberger R., Bristow M.R. Effect of vasoactive intestinal peptide on myocardial contractility and coronary blood flow in the dog: comparison with isoproterenol and forskolin. J. Cardiovasc. Pharmacol. 12:1988;365-371
3. Anderson F.L., Hanson G.R., Reid B., Thorpe M., Kralios A.C. VIP and NPY in canine hearts. Distribution and effect of total and selective parasympathetic denervation. Am. J. Physiol. 265:1993;H91-H95
4. Anderson F.L., Kralios A.C., Reid B., Hanson G.R. Release of vasoactive intestinal peptide and neuropeptide Y from canine heart. Am. J. Physiol. 265:1993;H959-H965
5. Belardinelli L., Fenton R.A., West A., Linden J., Althaus J.S., Berne R.M. Extracellular action of adenosine and the antagonism by aminophylline on the atrioventricular conduction of isolated perfused guinea pig and rat hearts. Circ. Res. 51:1982;569-579
6. Beny J.L., Brunet P.C., Huggel H. Effect of mechanical stimulation, substance P and vasoactive intestinal polypeptide on the electrical and mechanical activities of circular smooth muscles from pig coronary arteries contracted with acetylcholine: role of endothelium. Pharmacology. 33:1986;61-68
7. Brum J.M., Bove A.A., Sufan Q., Reilly W., Go V.L.W. Action and localization of vasoactive intestinal peptide in the coronary circulation: evidence for nonadrenergic, noncholinergic coronary regulation. J. Am. Coll. Cardiol. 7:1986;406-413
8. Criddle D.N., Dewar G.H., Radniknam M., Wathey W.B., Woodward B. The synthesis, and structure-activity relationships of some long chain acyl carnitine esters on the coronary circulation of the rat isolated heart. J. Pharm. Pharmacol. 43:1991;636-639
9. DeHaven W.I., Cuevas J. Heterogeneity of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide receptors in rat intrinsic cardiac neurons. Neurosci. Lett. 328:2002;45-49
10. Edvinsson L., Fredholm B.B., Hamel E., Jansen I., Verrecchia C. Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat. Neurosci. Lett. 58:1985;213-217
11. Feliciano L., Henning R.J. Vagal nerve stimulation releases vasoactive intestinal peptide which significantly increases coronary artery blood flow. Cardiovasc. Res. 40:1998;45-55
12. Forssmann W.G., Triepel J., Daffner C., Heym C.H., Cuevas P., Noble M.I.M., Yanaihara N. Vasoactive intestinal peptide in the heart. Ann. N.Y. Acad. Sci. 527:1988;405-420
13. Ganz P., Sandrock A.W., Landis S.C., Leopold J., Gimbrone M.A. Jr., Alexander R.W. Vasoactive intestinal peptide: vasodilatation and cyclic AMP generation. Am. J. Physiol. 250:1986;H755-H760
14. G-monomethyl arginine in endothelium-denuded vessels. Br. J. Pharmacol. 102:1991;567-572
15. Gozes I., Fridkin M., Hill J.M., Brenneman D.E. Pharmaceutical VIP: prospects and problems. Curr. Med. Chem. 6:1999;1019-1034
16. ′ -dideoxyadenosine in the isolated perfused guinea-pig heart J. Mol. Cell. Cardiol. 25:1993;331-338
17. Henning R.J., Sawmiller D.R. Vasoactive intestinal peptide: cardiovascular effects. Cardiovasc. Res. 49:2001;27-37
18. Hoover D.B. Effects of guinea pig vasoactive intestinal peptide on the isolated perfused guinea pig heart. Peptides. 10:1989;343-347
19. Huang M., Rorstad O.P. Cerebral vascular adenylate cyclase: evidence for coupling to receptors for vasoactive intestinal peptide and parathyroid hormone. J. Neurochem. 43:1984;849-856
20. Ignarro L.J., Byrns R.E., Buga G.M., Wood K.S. Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and VIP. Am. J. Physiol. 253:1987;H1074-H1082
21. Itoh H., Lederis K.P., Rorstad O.P. Relaxation of isolated bovine coronary arteries by vasoactive intestinal peptide. Eur. J. Pharmacol. 181:1990;199-205
22. Itoh T., Sasaguri T., Makita Y., Kanmura Y., Kuriyama H. Mechanisms of vasodilation induced by vasoactive intestinal polypeptide in rabbit mesenteric artery. Am. J. Physiol. 249:1985;H231-H240
23. Jackson W.F. Ion channels and vascular tone. Hypertension. 35:2000;173-178
24. Jin J.G., Murthy K.S., Grider J.R., Makhlouf G.M. Activation of distinct cAMP- and cGMP-dependent pathways by relaxant agents in isolated gastric muscle cells. Am. J. Physiol. 264:1993;G470-G477
25. Kalfin R., Maulik N., Engelman R.M., Cordis G.A., Milenov K., Kasakov L., Das D.K. Protective role of intracoronary vasoactive intestinal peptide in ischemic and reperfused myocardium. J. Pharmacol. Exp. Ther. 268:1994;952-958
26. Kawasaki J., Kobayashi S., Miyagi Y., Nishimura J., Fujishima M., Kanaide H. The mechanisms of the relaxation induced by vasoactive intestinal peptide in the porcine coronary artery. Br. J. Pharmacol. 121:1997;977-985
27. Kelm M., Schrader J. Control of coronary vascular tone by nitric oxide. Circ. Res. 66:1990;1561-1575
28. 2a-receptor activation increases contractility in isolated perfused hearts. Am. J. Physiol. 279:2000;H1472-H1481
29. Popma J.J., Smitherman T.C., Bedotto J.B., Eichhorn E.J., Said S.I., Dehmer G.J. Direct coronary vasodilation induced by intracoronary vasoactive intestinal peptide. J. Cardiovasc. Pharmacol. 16:1990;1000-1006
30. Smitherman T.C., Popma J.J., Said S.I., Krejs G.J., Dehmer G.J. Coronary hemodynamic effects of intravenous vasoactive intestinal peptide in humans. Am. J. Physiol. 257:1989;H1254-H1262
31. Ulrich C.D. II, Holtmann M., Miller L.J. Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors. Gastroenterology. 114:1998;382-397
32. Unverferth D.V., O'Dorisio T.M., Muir W.W. III, White J., Miller M.M., Hamlin R.L., Magorien R.D. Effect of vasoactive intestinal polypeptide on the canine cardiovascular system. J. Lab. Clin. Med. 106:1985;542-550
33. Weihe E., Reinecke M., Forssmann W.G. Distribution of vasoactive intestinal polypeptide-like immunoreactivity in the mammalian heart. Interrelation with neurotensin- and substance P-like immunoreactive nerves. Cell Tissue Res. 236:1984;527-540
34. Yao W., Sheikh S.P., Ottesen B., Jorgensen J.C. Vascular effects and cyclic AMP production produced by VIP, PHM, PHV, PACAP-27, PACAP-38 and NPY on rabbit ovarian artery. Peptides. 17:1996;809-815